...
首页> 外文期刊>Nutrients >The Effects of Non-Nutritive Artificial Sweeteners, Aspartame and Sucralose, on the Gut Microbiome in Healthy Adults: Secondary Outcomes of a Randomized Double-Blinded Crossover Clinical Trial
【24h】

The Effects of Non-Nutritive Artificial Sweeteners, Aspartame and Sucralose, on the Gut Microbiome in Healthy Adults: Secondary Outcomes of a Randomized Double-Blinded Crossover Clinical Trial

机译:非营养人工甜味剂,阿斯巴甜和三氯蔗糖在健康成人肠道微生物组上的影响:随机双盲交叉临床试验的二次结果

获取原文
           

摘要

Non-nutritive artificial sweeteners (NNSs) may have the ability to change the gut microbiota, which could potentially alter glucose metabolism. This study aimed to determine the effect of sucralose and aspartame consumption on gut microbiota composition using realistic doses of NNSs. Seventeen healthy participants between the ages of 18 and 45 years who had a body mass index (BMI) of 20–25 were selected. They undertook two 14-day treatment periods separated by a four-week washout period. The sweeteners consumed by each participant consisted of a standardized dose of 14% (0.425 g) of the acceptable daily intake (ADI) for aspartame and 20% (0.136 g) of the ADI for sucralose. Faecal samples collected before and after treatments were analysed for microbiome and short-chain fatty acids (SCFAs). There were no differences in the median relative proportions of the most abundant bacterial taxa (family and genus) before and after treatments with both NNSs. The microbiota community structure also did not show any obvious differences. There were no differences in faecal SCFAs following the consumption of the NNSs. These findings suggest that daily repeated consumption of pure aspartame or sucralose in doses reflective of typical high consumption have minimal effect on gut microbiota composition or SCFA production.
机译:非营养的人造甜味剂(NNSS)可以具有改变肠道微生物的能力,这可能会改变葡萄糖代谢。本研究旨在利用现实剂量的NNSS确定三氯蔗糖和阿斯巴甜消费对肠道微生物群组合物的影响。选择了18至45岁之间的17岁及45岁的参与者,他们的体重指数(BMI)为20-25。他们进行了两周的洗涤期分隔了两年的治疗期。每个参与者消耗的甜味剂由标准化剂量为14%(0.425g)的Aspartame可接受的每日摄入(Adi),以及20%(0.136g)的三氯蔗糖。分析治疗前后收集的粪便样品用于微生物组和短链脂肪酸(SCFA)。在患有两个NNSS的治疗之前和之后最丰富的细菌分类群(家族和属)的中位相对比例没有差异。 Microbiota社区结构也没有表现出任何明显的差异。鼻窦消耗后,粪便SCFA没有差异。这些发现表明,每日重复消耗纯阿巴甜或蔗糖的剂量反射典型的高消耗对肠道微生物群组合物或SCFA生产具有最小的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号